A+O=D2 CONTROL YOUR VARIABLES DRUG DIVERSION VISANTE Trademark

Trademark Overview

On Friday, November 18, 2016, a trademark application was filed for A+O=D2 CONTROL YOUR VARIABLES DRUG DIVERSION VISANTE with the United States Patent and Trademark Office. The USPTO has given the A+O=D2 CONTROL YOUR VARIABLES DRUG DIVERSION VISANTE trademark a serial number of 87241507. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, November 1, 2024. This trademark is owned by Visante, Inc.. The A+O=D2 CONTROL YOUR VARIABLES DRUG DIVERSION VISANTE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business management services for pharmacy automation systems of others, namely, help pharmaceutical manufacturers and technology firms to expand their market reach while improving patient care through the optimal use of their products and services; Business consultation services related to the pharmacy field regarding clinical, operational and financial metrics relating to potential drug diversions, clinical assessment, work load efficiency, equipment utilization, inventory optimization, cost tracking, prescription refilling, discrepancy, and stock out and waste analysis
a+o=d2 control your variables drug diversion visante

General Information

Serial Number87241507
Word MarkA+O=D2 CONTROL YOUR VARIABLES DRUG DIVERSION VISANTE
Filing DateFriday, November 18, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, November 1, 2024
Registration Number5483574
Registration DateTuesday, June 5, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 20, 2018

Trademark Statements

Description of MarkThe mark consists of "A+O=D2" in block letters with the "2" being in superscript, the phrases "CONTROL YOUR VARIABLES" and "DRUG DIVERSION" are underneath and the stylized wording "VISANTE" is at the bottom, all over a shaded rectangular background.
Pseudo MarkA PLUS O=D TWO CONTROL YOUR VARIABLES DRUG DIVERSION VISANTE
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBusiness management services for pharmacy automation systems of others, namely, help pharmaceutical manufacturers and technology firms to expand their market reach while improving patient care through the optimal use of their products and services; Business consultation services related to the pharmacy field regarding clinical, operational and financial metrics relating to potential drug diversions, clinical assessment, work load efficiency, equipment utilization, inventory optimization, cost tracking, prescription refilling, discrepancy, and stock out and waste analysis
NOT AVAILABLE"DRUG DIVERSION"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, November 25, 2016
Primary Code035
First Use Anywhere DateSaturday, October 7, 2017
First Use In Commerce DateSaturday, October 7, 2017

Trademark Owner History

Party NameVISANTE CONSULTING LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressST. PAUL, MN 55101
Party NameVISANTE CONSULTING LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressST. PAUL, MN 55101
Party NameVisante, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSt. Paul, MN 55101
Party NameVisante, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSt. Paul, MN 55101
Party NameVisante, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Paul, MN 55101

Trademark Events

Event DateEvent Description
Tuesday, November 22, 2016NEW APPLICATION ENTERED
Friday, April 7, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 7, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 25, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 26, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, February 25, 2017ASSIGNED TO EXAMINER
Tuesday, March 7, 2017NON-FINAL ACTION WRITTEN
Tuesday, March 7, 2017NON-FINAL ACTION E-MAILED
Tuesday, March 7, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 21, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 22, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 9, 2017TEAS AMENDMENT OF USE RECEIVED
Tuesday, October 10, 2017USE AMENDMENT FILED
Tuesday, October 10, 2017AMENDMENT TO USE PROCESSING COMPLETE
Thursday, October 12, 2017USE AMENDMENT ACCEPTED
Wednesday, September 13, 2017NON-FINAL ACTION WRITTEN
Wednesday, September 13, 2017NON-FINAL ACTION E-MAILED
Wednesday, September 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 18, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 18, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 18, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 12, 2017NON-FINAL ACTION E-MAILED
Thursday, October 12, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 9, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 15, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, October 12, 2017NON-FINAL ACTION WRITTEN
Friday, October 13, 2017NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, January 23, 2018ASSIGNED TO LIE
Thursday, January 25, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 25, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 15, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, February 15, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 5, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, September 3, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 15, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, February 15, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, September 3, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 16, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 16, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 14, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 16, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 5, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, May 13, 2024TEAS SECTION 8 & 15 RECEIVED
Friday, November 1, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 1, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, November 1, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, May 1, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

diversion visante drug variables your control services clinical business their pharmacy assessment work load diversions relating